Denemek ALTIN - Özgür
'We Have Developed Over 15000 NCEs This Year'
Bio Spectrum
|November 2019
A leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery and development, TCG Lifesciences Pvt. Limited started its operations in 2001 in Kolkata and currently has a presence in the United States, Europe, and Japan.
Formerly known as Chembiotek Research International, TCG Lifesciences (TCGLS) has a strong talent pool of more than 800 qualified and trained scientists, drawn from the best domestic and international institutes and industry. The company’s services span chemistry, in vitro and in vivo pharmacology, analytical development and validation, and specialty chemicals. TCGLS offers specific, functional solutions to integrated projects across multiple therapeutic areas with a specific focus on Inflammation & Pain, Infectious Diseases, Central Nervous System and Oncology. Its research infrastructure includes world-class chemistry and biology laboratories, animal facility, electrophysiology laboratory, BSL 2 laboratory, and cGMP facilities at the R&D center in Kolkata.
In addition, the company has a wholly-owned USFDA approved subsidiary Clininvent Research Pvt. Ltd. in Hyderabad. Clininvent offers custom manufacturing services for the production of cGMP Active Pharmaceutical Ingredients (NCEs and Generic APIs), GMP ready regulatory starting materials (RSMs) to the pharma and fine chemicals industries for the production of active ingredients, excipients, starting materials, and intermediates. Together with Clininvent, TCGLS has been providing an end-to-end solution for drug discovery, development, and commercialization companies for the past 18 years. During it’s recently conducted survey on the BioServices industry in India, BioSpectrum interacted in detail with Swapan Bhattacharya, Managing Director, TCGLS, who has taken the company to a global leadership level in the research services space since its inception in 2001. Edited Excerpts;
What are the key highlights at TCG Lifesciences this year?
Bu hikaye Bio Spectrum dergisinin November 2019 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Bio Spectrum'den DAHA FAZLA HİKAYE
Bio Spectrum
Building Breakthrough Medical Devices
Dr Ria Khurana founded RNT Health Insights, a Chandigarh-based healthtech startup specialising in Al-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, in 2022 along with Dr Tanmaya Gulati.
2 mins
January 2026
Bio Spectrum
Bridging classical epidemiology with modern science
A physician scientist with a MBBS from Lady Hardinge Medical College, (University of Delhi), a post-graduation in Paediatrics and a PhD from All India Institute of Medical Sciences (AIIMS), New Delhi, Prof.Shinjini Bhatnagar served as Professor of Eminence at Translational Health Science and Technology Institute (THSTI) until February 2023 and was subsequently appointed Distinguished Professor at THSTI until May 2025.
2 mins
January 2026
Bio Spectrum
"AI, Automation & Analytics: A new era of modern microbiology testing!"
Pharmaceutical manufacturing is undergoing a paradigm shift.
4 mins
January 2026
Bio Spectrum
The CRISPR Moment
CRISPR (clustered regularly interspaced short palindromic repeats) technology is ushering in a new era of gene and cell therapy, offering more precision and potential for treating genetic disorders, cancer, and infectious diseases.
2 mins
January 2026
Bio Spectrum
Leveraging Microfluidic Technology for mRNA-LNP Manufacturing
Over the past five years, messenger RNA (mRNA) therapeutics have evolved from experimental concepts into lifesaving medicines.
2 mins
January 2026
Bio Spectrum
Demonstrating India's Vaccine Capabilities
Havisure is India's first and only indigenously developed Hepatitis A vaccine, to address one of the country's most persistent public health challengeswidespread Hepatitis A infections caused by inadequate sanitation and contaminated food and water.
2 mins
January 2026
Bio Spectrum
Inspiring Future Generations
A PhD in molecular biology from the University of Cambridge, UK, Prof. Gaiti Hasan is a Distinguished Fellow at the National Centre for Biological Sciences (NCBS), Bengaluru.
2 mins
January 2026
Bio Spectrum
A Landmark for India's Antibiotic Innovation
After three decades of research and hard work, India has led the way with the creation of Nafithromycin, the country's first indigenous antibiotic.
2 mins
January 2026
Bio Spectrum
"Future vaccine innovation will be integration of R&D, regulatory support and manufacturing”
TechInvention Lifecare Limited, a vaccine focused biotechnology company headquartered in Mumbai, is recognised for its innovative contributions to global healthcare.
4 mins
January 2026
Bio Spectrum
Telangana: Building India's Most Credible Life Sciences Ecosystem
Telangana's recognition as BioSpectrum India's Best Performing State in Life Sciences 2025 is a timely validation of the direction the state has taken in recent years-one anchored in execution, responsiveness, and a clear understanding of where global life sciences value chains are headed.
4 mins
January 2026
Translate
Change font size
